Lung cancer remains one of the most widespread and deadliest malignant tumors globally, with a particularly high mortality rate among all cancers. Recently, immunotherapy, particularly immune ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

The FDA granted an orphan drug designation to PEP-010 for the treatment of patients with metastatic pancreatic cancer.

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

Understanding your tumor biology is key to finding the right treatment for pancreatic cancer. Identifying mutations, or changes in a [...] READ MORE ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...

In this video, Michael Cecchini, MD, discusses results of two clinical trials evaluating pamrevlumab in pancreatic cancer, which were presented at ASCO Gastrointestinal Cancers Symposium.

A team of researchers from Cleveland Clinic Genomic Medicine share insights from an early set of 19,000 patients to receive ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

NEIGHBOURS veteran Ian Smith has given an update on his health after being diagnosed with terminal cancer in December. The ...

Encouraging preclinical data supporting the use of DNase-based technology to target NETosis and address difficult to treat cancers ...